source Post navigation Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201 – Yahoo Finance FDA accepts sNDA for empagliflozin in children with type 2 diabetes – Contemporary Pediatrics